Atara Biotherapeutics, Inc (ATRA)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$8.81+$0.2700 (+3.16%) on the dayAs of the close; data may be delayed.
ATRA price, last 12 months
Key stats
- Previous close
- $8.54
- Open
- $8.60
- Day range
- $8.54 – $8.99
- 52-week range
- $3.92 – $19.15
- Volume
- 31.2K
- Avg volume (20 days)
- 46.6K
- Market cap
- $88.4M
Performance
1W−9.1%
1M−6.1%
3M−16.2%
6M+87.1%
YTD−51.3%
1Y−38.2%
vs S&P 500, 1Y−55.0 pts
Technicals and fundamentals
About Atara Biotherapeutics, Inc
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $88.4M